Cello Health (CLL)

Sector:

Health Care

Index:

FTSE AIM All-Share

 129.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 137.50p
  • 52 Week Low: 96.00p
  • Currency: UK Pounds
  • Shares Issued: 104.77m
  • Volume: 0
  • Market Cap: £135.16m
  • RiskGrade: 66

Cello Health Overview

Cello Health is in the health care sector and is currently trading at 129.00p per share. In the last year Cello Health's share price has ranged from 96.00p to 137.50p and brokers are currently rating this stock as 'buy'.

Key Personnel

CEO: Mark Scott
Executive Director: Julia Ralston
Group COO: Stephen Highley
Group Finance Director: Mark Bentley
Independent Non-Executive Director: Jo LeCouilliard
Independent Non-Executive Director: Clifford Tompsett
Non-Executive Chairman: Christopher Jones
Non-Executive Dir: Michele Luzi

Contact Details

Address: Queens House, 8-9 Queen Street, London, United Kingdom, EC4N 1SP
Phone: +44 (0)20 7812 8460
Fax: +44 (0)20 7253 5376

Listings

Sector: Health Care(LSE)
Index: FTSE AIM All-Share
ISIN: GB00B0310763

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Cello Health Market Data

Currency UK Pounds
Share Price 129.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 137.50p
52 Week Low 96.00p
Volume 0
Shares Issued 104.77m
Market Cap £135.16m
RiskGrade 66

Cello Health Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
65.66% below the market average65.66% below the market average65.66% below the market average65.66% below the market average65.66% below the market average
82.86% above the sector average82.86% above the sector average82.86% above the sector average82.86% above the sector average82.86% above the sector average
Price Trend
42.45% above the market average42.45% above the market average42.45% above the market average42.45% above the market average42.45% above the market average
35.00% above the sector average35.00% above the sector average35.00% above the sector average35.00% above the sector average35.00% above the sector average
Income
13.66% above the market average13.66% above the market average13.66% above the market average13.66% above the market average13.66% above the market average
60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average
Growth
33.21% below the market average33.21% below the market average33.21% below the market average33.21% below the market average33.21% below the market average
41.18% below the sector average41.18% below the sector average41.18% below the sector average41.18% below the sector average41.18% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 2
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Cello Health Dividends

  Latest Previous
  Interim Final
Ex-Div 03-Oct-19 25-Apr-19
Paid 01-Nov-19 24-May-19
Amount 1.15p 2.75p

Trades for --2019

Time Volume / Share Price
0 @ 0.000p

Cello Health Key Personnel

CEO Mark Scott

Top of Page